Beverage thick slurry formula containing xanthophyll and taurine as well as preparation method and application of beverage thick slurry formula

By using high shear dispersed emulsification technology in food, and combining taurine to form a concentrated slurry with high bioavailability, the problem of insufficient water solubility of lutein is solved and better Vision protection effect.

CN118985805APending Publication Date: 2024-11-22ZHEJIANG GUOBANG PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411206278.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Lutein is limited in food and medicines due to its poor water solubility and stability, resulting in low bioavailability and inability to effectively prevent cellular aging and vision loss.

Method used

Using the formula of 20% lutein powder, food-grade soy phospholipids and fructose syrup, the lutein is embedded and dispersed through high shear dispersion emulsification technology to improve its water solubility, and combined with 99.3% taurine to form a Concentrated slurry with good bioavailability.

Benefits of technology

The water solubility and bioavailability of lutein are improved, and the problems of insufficient water solubility and poor taste in the prior art are overcome, providing a higher visual protection effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118985805A_ABST
    Figure CN118985805A_ABST
Patent Text Reader

Abstract

On one hand, the invention discloses a lutein thick slurry formula, the formula comprises lutein powder, soybean lecithin, high fructose corn syrup and water, and when the lutein thick slurry (50mL) is prepared, the usage amounts of all the components are as follows: 74.2 mg of lutein powder (20.0%); 152.9 mg of soybean phospholipid (food grade); 1.1 g of high fructose corn syrup; and 46.7 g of water. The invention also discloses a lutein-taurine thick slurry formula, the formula comprises the following components: 75.4 mg of lutein powder (20.0%), 75.4 mg of taurine powder (20.0%), 75.4 mg of soybean lecithin (20.0%), 75.4 mg of high fructose corn syrup (20.0%) and 25.4 mg of water (20.0%) when the lutein-taurine thick slurry (50mL) is prepared. 2.0 g of taurine (99.3%); 163.6 mg of soybean phospholipid (food grade); 1.5 g of high fructose corn syrup; and 40.4 g of water. The lutein-taurine thick slurry disclosed by the invention has the advantages of large lutein carrying capacity, high in-vivo solubility, good bioavailability and the like, and a good application basis is provided for subsequent development of compound foods and functional foods.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of functional health food, and specifically relates to a formula of a beverage concentrate containing lutein and taurine, and a preparation method and application thereof. Background Art

[0002] Lutein is an important carotenoid and a natural substance widely found in vegetables, flowers, fruits and other plants. Modern medical experiments have proved that the natural lutein contained in plants is an excellent antioxidant. 1g of lutein is equivalent to the value of 1g of gold, and it is known as "plant gold". Adding a certain amount of lutein to food can prevent cell aging and organ aging, and can also prevent vision loss and blindness caused by age-related macular degeneration of the retina.

[0003] Lutein is a natural plant pigment with multiple biological activities. Although it has been widely used in food production as a natural pigment and dietary nutrient as early as 1996, most of lutein is an unsaturated structure, resulting in poor water solubility and stability, easy degradation and inactivation, and low oral bioavailability, which greatly affects its efficacy. These factors limit its widespread use in food, medicine and cosmetics.

[0004] It is a pity that the human body can neither synthesize lutein by itself nor convert it from other substances in the body. It can only be ingested through "eating". The main sources of lutein in food are green plants and yellow fruits that perform photosynthesis. After being absorbed by the gastrointestinal tract, it reaches the eyes through the blood circulation. Most of the lutein absorbed by the eyes is concentrated in the macula, and a small part is distributed in the lens. Lutein is a fat-soluble substance and is absorbed very slowly in the macula. Although lutein is absorbed by the gastrointestinal tract and enters the blood circulation, it quickly reaches the equilibrium concentration in the blood, but there is a delay of three to four months for it to enter the macula from the blood. However, once the absorption of lutein is initiated, it will cause a slow but continuous increase. At this time, even if the oral intake is reduced and the blood concentration decreases, the amount of lutein in the macula can still maintain a stable and effective state.

[0005] Taurine is a sulfur-containing amino acid in animals. It is widely distributed in the brain, heart, liver, kidney, ovary, uterus, skeletal muscle, blood, saliva and milk of humans and animals in the form of free amino acids. The highest concentration is in the pineal gland, retina, pituitary gland, adrenal gland and other tissues. In the heart of mammals, free taurine accounts for as much as 50% of the total free amino acids. Many studies have found that taurine is an active substance that regulates the normal physiological activities of the body. It has a wide range of biological functions such as anti-inflammatory, analgesic, maintaining the body's osmotic pressure balance, maintaining normal visual function, regulating cell calcium balance, lowering blood sugar, regulating nerve conduction, participating in endocrine activities, regulating lipid digestion and absorption, increasing heart contractility, improving the body's immune ability, enhancing cell membrane antioxidant capacity, and protecting myocardial cells.

[0006] Although both lutein and taurine are beneficial nutrients, their roles cannot replace each other. Lutein mainly plays an anti-oxidation, anti-inflammatory, and vision protection role, while taurine mainly plays a role in improving heart function, promoting fat metabolism, and enhancing immunity. Therefore, it cannot be simply said that taurine can replace lutein.

[0007] In summary, taurine and lutein are two different nutrients, and their effects and mechanisms of action are also different, so it cannot be simply said that taurine can replace lutein. In order to obtain the effects of multiple nutrients, people should maintain a diverse diet and consume a variety of vegetables, fruits, meat, fish, dairy products and other foods. In order to adapt to the high-intensity and high-efficiency work needs of modern society, to ensure people's vision level and eye health, and to maintain sufficient physical energy, it is necessary to develop a concentrated syrup formula containing lutein and / or taurine to improve the body's absorption and comprehensive utilization of lutein and taurine. Summary of the invention

[0008] Therefore, in order to make up for the deficiencies in the existing lutein / taurine and its composite products in increasing the water solubility of lutein and improving the comprehensive utilization efficiency of lutein-taurine in the human body, the present invention aims to provide a lutein and taurine beverage concentrate formula, a preparation method and application thereof.

[0009] The present invention discloses a lutein concentrate formula, which comprises lutein powder containing 20% ​​lutein, food-grade soybean lecithin, fructose syrup and water, wherein when 50 mL of lutein concentrate is prepared, the contents of the components are respectively:

[0010] Lutein powder: 74.2mg;

[0011] Soybean lecithin: 152.9 mg;

[0012] Fructose syrup: 1.1g;

[0013] Water: 46.7 g.

[0014] On the other hand, the present invention also discloses a lutein-taurine concentrated slurry formula, which includes lutein powder containing 20% ​​lutein, 99.3% taurine, food-grade soybean lecithin, fructose syrup and water, wherein when 50 mL of lutein-taurine concentrated slurry is prepared, the contents of the components are respectively:

[0015] Lutein powder: 75.4mg;

[0016] Taurine: 2.0g;

[0017] Soybean lecithin: 163.6 mg;

[0018] Fructose syrup: 1.5g;

[0019] Water: 40.4g.

[0020] On the other hand, the present invention also discloses a lutein-taurine concentrated slurry formula, which includes crystals containing 75% lutein, 99.3% taurine, food-grade soybean lecithin, fructose syrup and water, wherein when 50 mL of lutein-taurine concentrated slurry is prepared, the contents of each component are respectively:

[0021] Lutein crystals: 23.6mg;

[0022] Taurine: 2.0g;

[0023] Soybean lecithin: 45.2 mg;

[0024] Fructose syrup: 1.5g;

[0025] Water: 46.4g.

[0026] In another aspect, the present invention further discloses a method for preparing the lutein concentrate, the method comprising the following steps:

[0027] (1) Place soybean lecithin in a 100 mL beaker, add appropriate amount of hot water and place in a 50°C water bath and stir until fully dispersed;

[0028] (2) Add lutein and continue to stir thoroughly in the water bath until the water volume reaches 40 mL;

[0029] (3) Use a high shear dispersing emulsifier to perform shear emulsification until the lutein is completely embedded and dispersed;

[0030] (4) After the concentrated slurry is adjusted to a predetermined volume, the lutein concentrated slurry is flavored with fructose syrup and then adjusted to a predetermined volume of 50 mL.

[0031] (5) Shear and disperse evenly again, and filter through a 300-mesh filter;

[0032] (6) The filtrate was placed in a 50 mL brown glass bottle and sterilized at 100°C for 15 min.

[0033] (7) Label and store at room temperature.

[0034] In another aspect, the present invention further discloses a method for preparing the lutein-taurine concentrated slurry, characterized in that the method comprises the following steps:

[0035] (1) Place soybean lecithin in a 100 mL beaker, add appropriate amount of hot water, and stir in a 50°C water bath until it is completely dispersed and dissolved;

[0036] (2) Add taurine and stir in a water bath until completely dissolved;

[0037] (3) Add lutein and continue to stir thoroughly in the water bath until the water volume reaches 40 mL;

[0038] (4) using a high shear dispersing emulsifier to perform shear emulsification until the lutein is completely embedded and dispersed;

[0039] (5) After the concentrated slurry is adjusted to a predetermined volume, the lutein-taurine concentrated slurry is flavored with fructose syrup and then adjusted to a predetermined volume of 50 mL;

[0040] (6) Properly shear and disperse the above concentrated slurry again, and filter it through a 300-mesh filter;

[0041] (7) The filtrate was placed in a 50 mL brown glass bottle and sterilized at 100°C for 15 min.

[0042] (8) Label and store at room temperature.

[0043] On the other hand, the present invention also discloses an application of the lutein-taurine concentrate formula in preparing a beverage concentrate containing lutein-taurine.

[0044] The lutein concentrate formula and two lutein-taurine concentrate formulas provided by the present invention have good water solubility and good taste, overcoming the problems of insufficient water solubility and poor taste of lutein in the prior art, and provide a useful reference for the development of lutein series beverage concentrates.

[0045] At the same time, the lutein-taurine concentrate prepared by the present invention has a good bioavailability advantage and is superior to similar products on the market, laying a good foundation for the subsequent preparation of beverage concentrates containing this formula, food development and functional evaluation research.

[0046] In addition, the inventors found during the research and development process that the reason why the lutein content in existing commercial products is low is that the preparation method is not suitable. The present invention optimizes the method, uses a suitable emulsifier, and uses high shear dispersion emulsification technology to completely disperse and embed the lutein molecules and increase the solubility. The lutein-taurine concentrate prepared by this method can load a higher content of lutein. BRIEF DESCRIPTION OF THE DRAWINGS

[0047] Figure 1 Formula 1 Lutein powder (5.8%).

[0048] Figure 2 Formula 2 Lutein powder (20.0%) (before AC filtration, after DF filtration).

[0049] Figure 3 Formula 3 Lutein oil (20.0%).

[0050] Figure 4 Formula 4 Lutein crystals (75.0%).

[0051] Figure 5 Formula 5 Lutein powder (5.8%) + Taurine.

[0052] Figure 6 Formula 6 Lutein powder (20.0%) + taurine (before A1-C1 filtration, after D1-F1 filtration).

[0053] Figure 7 Formula 7 Lutein oil (20.0%) + taurine.

[0054] Figure 8 Formula 8 Lutein crystals (75.0%) + taurine.

[0055] Fig. 9 Lutein plasma concentration-time curve. DETAILED DESCRIPTION

[0056] The present invention is further described below in conjunction with specific examples, but each example is not intended to limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art. Unless otherwise specified, the reagents and materials used in the following examples are commercially available.

[0057] Example 1: Preparation and comparison of lutein concentrate

[0058] 1. Experimental Materials

[0059] 1. Instruments and reagents: high shear dispersing emulsifier (Fluco-FA25D), vertical pressure steam sterilizer (Boxun-YXQ-LB-50SII), soybean lecithin (food grade, PC ≥ 20%; Shenyang Tianfeng Biopharmaceutical Co., Ltd.), fructose syrup (Zhejiang Huakang Pharmaceutical Co., Ltd.), vitamin E (Ve, donated by Zhejiang Kanglaite Pharmaceutical Co., Ltd.).

[0060] 2. Samples: Lutein powder (5.8%, Xinchang Pharmaceutical Factory, Zhejiang Medicine Co., Ltd.), Lutein powder (20.0%, Zhejiang Huisong Pharmaceutical Co., Ltd.), Lutein oil (20.0%, Zhejiang Huisong Pharmaceutical Co., Ltd.), Lutein crystals (75.0%, Zhejiang Huisong Pharmaceutical Co., Ltd.).

[0061] 2. Experimental steps

[0062] Table 1 Lutein concentrate formula composition and dosage

[0063]

[0064] Four groups of lutein formulas were trial-produced according to the formula number sequence in Table 1. The specific experimental steps are as follows:

[0065] (1) Place soybean lecithin in a 100 mL beaker, add appropriate amount of hot water and place in a 50°C water bath and stir until completely dissolved;

[0066] (2) Add lutein and continue to stir thoroughly in a water bath. After adding water to 40 mL, use a high shear dispersing emulsifier for shear emulsification;

[0067] (3) Add Ve and continue shearing and emulsifying until the lutein is completely embedded and dispersed to form an orange-yellow uniform emulsion;

[0068] (4) After adding water to the concentrated slurry to a predetermined volume, the concentrated lutein slurry is flavored with fructose syrup and then the volume is adjusted to 50 mL;

[0069] (5) Shear and disperse evenly again, and filter through a 300-mesh filter;

[0070] (6) The filtrate was placed in a 50 mL brown glass bottle and sterilized at 100°C for 15 min.

[0071] (7) Label and store at room temperature.

[0072] 3. Results Analysis

[0073] Formula 1 dissolves better ( Figure 1 ), but it tastes powdery. Formula 2 has better shear emulsification effect; after filtering with a 300-mesh filter, the orange-yellow filtrate has better stability ( Figure 2 ). Recipe 3( Figure 3) shows that before and after Ve is added, lutein oil is very easy to separate and adhere to the four walls, and the dispersion and emulsification effect is poor, indicating that lutein oil is not suitable for this type of concentrated slurry compounding. Formula 4 ( Figure 4 ) When Ve is not added, the shear emulsification effect of lutein crystals is better. After adding Ve, the dispersion and emulsification effect becomes worse and the dissolution is incomplete. This shows that when compounding lutein concentrate, the higher the lutein content in the raw material, the better.

[0074] 4. Discussion and Conclusion

[0075] This experiment uses soybean lecithin with strong emulsification, wetting and dispersing activity as an emulsifier, and uses high shear technology to first make lutein into an "oil-in-water" microemulsion, thereby improving its water solubility and bioavailability in the human body. It is better than the current esterified lutein in water solubility, and uses Ve as an antioxidant ingredient, fructose syrup for flavor correction, and other auxiliary ingredients are few. In the experiment, lutein samples with different contents and different forms were used to trial-produce lutein concentrate, in which the lutein content was controlled between the daily common health care dose and the effective dose, that is, 6mg-20mg per day. During the development process, it was also found that the lower the lutein content in the raw material, the more auxiliary ingredients it contained, and the taste of the lutein concentrate was also poor. Based on the experimental results, formula 2, that is, using lutein powder with a lutein content of 20%, adding soybean lecithin and Ve compound, the shear emulsification trial-produced concentrate has a better effect. During the experiment, attempts were made to adjust the order of adding materials according to the characteristics of the raw materials, such as adding Ve to lutein oil first, or using high-content lutein crystals as raw materials and emulsifying and dispersing soybean lecithin before adding Ve for protection, but all of these were not suitable.

[0076] Example 2: Lutein-Taurine Concentrate Formula

[0077] 1. Experimental Materials

[0078] 1. Instruments and reagents: high shear dispersing emulsifier (Fluco-FA25D), vertical pressure steam sterilizer (Boxun-YXQ-LB-50SII), soybean lecithin (food grade, PC ≥ 20%; Shenyang Tianfeng Biopharmaceutical Co., Ltd.), fructose syrup (Zhejiang Huakang Pharmaceutical Co., Ltd.), vitamin E (Ve, Zhejiang Kanglaite Pharmaceutical Co., Ltd.).

[0079] 2. Samples: taurine (99.3%, Qianjiang Yongan Pharmaceutical Co., Ltd.), lutein powder (5.8%, Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory), lutein powder (20.0%, Zhejiang Huisong Pharmaceutical Co., Ltd.), lutein oil (20.0%, Zhejiang Huisong Pharmaceutical Co., Ltd.), lutein crystals (75.0%, Zhejiang Huisong Pharmaceutical Co., Ltd.).

[0080] 2. Experimental steps

[0081] Table 2 Lutein-taurine concentrated syrup formula composition and dosage (preparation 50mL)

[0082]

[0083] Four groups of lutein formulas were trial-produced according to the formula number sequence in Table 1. The specific experimental steps are as follows:

[0084] (1) Place soybean lecithin in a 100 mL beaker, add appropriate amount of hot water and stir in a 50°C water bath until fully dispersed;

[0085] (2) Add lutein and continue to stir thoroughly in the water bath until the water volume reaches 40 mL;

[0086] (3) using a high shear dispersing emulsifier to perform shear emulsification until the lutein is completely dispersed and embedded;

[0087] (4) Add taurine and stir in a water bath to completely dissolve;

[0088] (5) Add Ve, first put it in a water bath for thorough stirring and dispersion, and then shear it with a high shear dispersing emulsifier;

[0089] (6) After adding water to the concentrated slurry to a predetermined volume, the concentrated lutein slurry is flavored with fructose syrup and then the volume is adjusted to 50 mL;

[0090] (7) Shear and disperse evenly again, and filter through a 300-mesh filter;

[0091] (8) The filtrate was placed in a 50 mL brown glass bottle and sterilized at 100°C for 15 min.

[0092] (9) Label and store at room temperature.

[0093] 3. Results

[0094] Recipe 5( Figure 5 ) dissolves better, but tastes powdery. Figure 6 ) and Formula 8( Figure 8 ) The shear emulsification effect is good, but there are a small amount of granular insoluble impurities, which can be basically filtered out after passing through a 300-mesh filter. Formula 7 ( Figure 7 ) After adding a large amount of soybean lecithin, the dispersion and emulsification effect is still poor and it is basically insoluble.

[0095] 4. Discussion and Conclusion

[0096] In this experiment, taurine was added on the basis of Example 1, and the formula was optimized according to the experimental results. The results showed that the addition of an appropriate amount of taurine had a certain effect on the taste of lutein after shear emulsification by soybean lecithin, but did not change the stability and color of the composite concentrated slurry. However, soybean lecithin had a better emulsification and dispersion effect on lutein powder and lutein crystals under compounding conditions, and did not improve the emulsification of lutein oil and Ve.

[0097] In summary, the compound taurine concentrates of Formula 6 (20.0% lutein powder) and Formula 8 (75.0% lutein crystals) have better effects. Taking into account factors such as cost, Formula 6 (20.0% lutein powder) is more suitable. Based on the original intention of adding Ve to provide antioxidant protection for lutein with many unsaturated bonds and easily oxidized and inactivated, it is not the most suitable for lutein oil. Subsequently, based on Formula 6 (20.0% lutein powder), combined with the above-mentioned emulsification effect, Ve will first be dissolved in a suitable medium such as dimethyl sulfoxide (DMSO), and then added as an antioxidant excipient to the lutein concentrate that has been shear-emulsified by soybean lecithin, and then sheared and dispersed evenly again.

[0098] Example 3: Lutein-taurine concentrated syrup bioavailability experiment

[0099] Bioavailability refers to the relative amount and rate of drug absorbed by the body into the blood circulation. It is an indicator used to evaluate the degree of absorption of the preparation. It is usually expressed as B, B = (A / D) × 100%. A is the amount entering the systemic circulation, and D is the oral dose. There are many factors that affect bioavailability, including the size of drug particles, crystal form, compactness of fillers, excipients and production process.

[0100] Bioavailability can be expressed in two ways: absolute and relative. Two routes of administration are used: one intravenous injection and one oral administration. Blood samples are collected at different time points to measure the drug concentration and calculate the area under the drug concentration-time curve (AUC).

[0101] (1) Absolute bioavailability: refers to the percentage of the drug absorbed by the body when the drug is 100% utilized when injected intravenously and when the drug is in other dosage forms with the same dose, i.e. AUC oral / AUC intravenous = absolute bioavailability

[0102] (2) Relative bioavailability: It is based on the assumption that a certain dosage form (such as oral aqueous preparation) is 100% utilized, and then the percentage utilization of other dosage forms of the drug under the same conditions is determined.

[0103] Therefore, bioavailability is also an important indicator to measure the efficacy of certain dosage forms.

[0104] 1. Experimental Materials

[0105] 1. Instruments and reagents: Lutein powder (20.0%, Zhejiang Huisong Pharmaceutical Co., Ltd.); taurine (99.3%, Qianjiang Yongan Pharmaceutical Co., Ltd.); ergosterol (≥98%, Chengdu Desite Biotechnology Co., Ltd.); soybean lecithin (food grade, PC ≥20%; Shenyang Tianfeng Biopharmaceutical Co., Ltd.); FA25D high shear dispersing emulsifier (Germany, Fluko).

[0106] 2. Experimental animals: SD rats, both male and female, weight (200±20) g, provided by Shanghai Jihui Experimental Animal Breeding Co., Ltd., license number: SCXK(Shanghai)2022-0009. Certificate number: 20240008002520.

[0107] 3. Sample preparation

[0108] (1) Lutein concentrated slurry: According to the method of Example 1, take lutein powder with a lutein content of 20% and an appropriate amount of food-grade soybean lecithin, add fructose syrup and water, shear and emulsify with a Fluko-FA25D high-shear dispersing emulsifier, filter with a 300-mesh filter, and sterilize to obtain an orange-yellow lutein concentrated slurry for later use.

[0109] (2) Lutein-taurine concentrated slurry: According to the method of Example 2, take lutein powder with a lutein content of 20%, 99.3% taurine and an appropriate amount of food-grade soybean lecithin, add fructose syrup and water, shear emulsify with a Fluko-FA25D high-shear dispersing emulsifier, filter with a 300-mesh filter, and sterilize to obtain a light yellow lutein-taurine concentrated slurry for later use.

[0110] (3) Lutein taurine chewable tablets (National Food and Health Note G20230202, Nanjing Tongrentang Liuhe Qiankun Health Development Co., Ltd.).

[0111] 2. Experimental process

[0112] 1. Grouping, administration and blood collection Lutein concentrate, lutein-taurine concentrate and lutein-taurine chewable tablets (made into liquid with 0.5% CMC-Na solution) were uniformly adjusted to a mass concentration of 4 mg / mL in terms of lutein. 30 rats were randomly divided into 3 groups (lutein concentrate group, lutein-taurine concentrate group and lutein-taurine chewable tablet group), 10 rats in each group, and 30 mg / kg was administered by gavage. 0.25 mL of blood was collected from the retro-orbital sinus at 0.5h, 1h, 1.5h, 2h, 2.5h, 3h, 4h, 6h, 12h and 18h, and placed in a centrifuge tube soaked with heparin, sealed, vortexed for 5s to mix, centrifuged at 3000 / min for 2min, and plasma was taken out and frozen for storage.

[0113] 2. Treatment of plasma samples According to the literature method, take an appropriate amount of ergosterol reference substance, dilute it to 886 ng / mL with acetonitrile as the internal standard solution, take 50 μL, add it to 100 μL of plasma sample, vortex mix for 1 min, add 1 mL of chloroform, vortex for 3 min, centrifuge at 4°C and 10,000 r / min for 10 min, collect the chloroform layer, blow dry in a 40°C nitrogen blower, add 100 μL of acetonitrile to re-dissolve, centrifuge at 10,000 r / min for 10 min, and take the supernatant for later use.

[0114] 3. Investigation of linear relationship Take an appropriate amount of lutein reference substance and prepare it into 65 ng / mL, 130 ng / mL, 260 ng / mL, 520 ng / mL, 1040 ng / mL and 2080 ng / mL solutions with acetonitrile. Take 100 μL of each solution into a centrifuge tube, blow dry with a nitrogen blower at 40°C, add 100 μL of blank plasma to the residue, vortex mix for 3 min, and process according to the method under "Plasma Sample Processing" to obtain plasma reference substance solutions (including internal standard) with mass concentrations of 65 ng / mL, 130 ng / mL, 260 ng / mL, 520 ng / mL, 1040 ng / mL and 2080 ng / mL, respectively. Regression was performed with the mass concentration of the reference substance as the abscissa (X) and the peak area ratio of lutein and ergosterol as the ordinate (Y). The equation was Y=0.0019X-0.2368 (r=0.9955), and a good linear relationship was obtained in the range of 65ng / mL-2080ng / mL.

[0115] 4. Methodological investigation

[0116] Take appropriate amount of 65ng / mL, 520ng / mL, and 2080ng / mL plasma reference solution respectively and perform chromatographic analysis under the same day [Hypersil ODS C 18Chromatographic column (250mm×4.6mm, 5μm); mobile phase methanol-acetonitrile-dichloromethane (55:25:20); volume flow rate 1.0ml / mL; column temperature 35℃; detection wavelength 446nm; injection volume 10μL] The sample was injected and measured 6 times, and the RSD of the peak area ratio of lutein and ergosterol was 6.07%, 5.28%, and 5.06%, respectively, indicating that the intra-day precision of this method is good; the same method was continuously measured for 6 days, once a day, and the RSD of the peak area ratio of the two was 9.45%, 6.00%, and 7.53%, respectively, indicating that the inter-day precision of this method is good. Take an appropriate amount of plasma sample 0.5h after administration, and inject and measure it under the above chromatographic conditions at 0h, 3h, 6h, 9h, 12h, and 24h. The RSD of the peak area ratio of lutein and ergosterol was 7.45%, indicating that the sample has good stability within 24h. Take appropriate amount of the above three mass concentrations of plasma reference solution, treat according to the method of "Experimental Process 2", and measure under the same chromatographic conditions as mentioned above. The average lutein recoveries were 93.68%, 96.09%, and 93.81%, respectively, and the RSDs were 6.21%, 7.34%, and 4.70%, respectively.

[0117] 3. Experimental results: Blood drug concentration-time curve Fig. 9 The main pharmacokinetic parameters are shown in Table 3.

[0118] Table 3 Main pharmacokinetic parameters of lutein (x±s, n=10)

[0119]

[0120] Note: Compared with Lutein Concentrate, Compared with lutein-taurine chewable tablets, #P<0.05, ##P<0.01.

[0121] The above results show that compared with the lutein concentrate group and the lutein taurine chewable tablet group, the lutein-taurine concentrate group max shortened (P<0.05), C max , AUC 0-t , AUC 0-∞ The relative bioavailability of lutein was increased by 3.71 times compared with lutein concentrate (P<0.01), but t 1 / 2 There was no significant change (P>0.05).

[0122] The results of in vivo pharmacokinetic studies showed that lutein-taurine concentrate max The significant shortening may be related to its faster drug release rate in the early stage; C maxThe relative bioavailability and bioavailability increased to 3.06 and 3.71 times, respectively. This may be because under the antioxidant protection of Ve, the lutein-taurine concentrate greatly improved the solubility and cumulative dissolution of lutein, solving the absorption bottleneck: lutein formed an "oil-in-water" emulsion configuration under soy lecithin emulsification, which enlarged the specific surface area of ​​lutein and increased the contact area with the gastrointestinal tract, which was beneficial to absorption and utilization.

[0123] In summary, the experimental results show that lutein-taurine concentrate has good bioavailability advantages, laying the foundation for subsequent functional evaluation research of this compound food.

[0124] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. A lutein concentrate formula, characterized in that: The formula includes lutein powder containing 20% ​​lutein, food-grade soybean lecithin, fructose syrup and water. The contents of the components in preparing 50 mL of lutein concentrated slurry are as follows: Lutein powder: 74.2mg; Soybean lecithin: 152.9 mg; Fructose syrup: 1.1g; Water: 46.7 g.

2. A lutein-taurine concentrated syrup formula, characterized in that: The formula includes lutein powder containing 20% ​​lutein, 99.3% taurine, food-grade soybean lecithin, fructose syrup and water, wherein the amounts of the components used to prepare 50 mL of lutein-taurine concentrated slurry are as follows: Lutein powder: 75.4mg; Taurine: 2.0g; Soybean lecithin: 163.6 mg; Fructose syrup: 1.5g; Water: 40.4g.

3. A lutein-taurine concentrated syrup formula, characterized in that: The formula includes lutein crystals containing 75% lutein, 99.3% taurine, food-grade soybean lecithin, fructose syrup and water, wherein the amounts of the components used to prepare 50 mL of lutein-taurine concentrated slurry are as follows: Lutein crystals: 23.6mg; Taurine: 2.0g; Soybean lecithin: 45.2 mg; Fructose syrup: 1.5g; Water: 46.4g.

4. A method for preparing the lutein concentrate according to claim 1, characterized in that: The method comprises the following steps: (1) Place soybean lecithin in a 100 mL beaker, add appropriate amount of hot water and place in a 50°C water bath and stir until it is completely dispersed and dissolved; (2) Add lutein and continue to stir thoroughly in a water bath until the water volume reaches 40 mL; (3) Use a high shear dispersing emulsifier to perform shear emulsification until the lutein is completely embedded and dispersed; (4) After adding water to the concentrated slurry to a predetermined volume, the concentrated lutein slurry after the predetermined volume is flavored with fructose syrup and then the volume is adjusted to 50 mL; (5) Shear and disperse evenly again, and filter through a 300-mesh filter; (6) The filtrate was placed in a 50 mL brown glass bottle and sterilized at 100°C for 15 min. (7) Label and store at room temperature.

5. A method for preparing the lutein-taurine concentrate according to claim 2, characterized in that: The method comprises the following steps: (1) Place soybean lecithin in a 100 mL beaker, add appropriate amount of hot water and place in a 50°C water bath and stir until completely dissolved; (2) Add taurine and stir in a water bath until completely dissolved; (3) Add lutein and continue to stir thoroughly in a water bath until the water volume reaches 40 mL; (4) Use a high shear dispersing emulsifier to perform shear emulsification until the lutein is completely embedded and dispersed; (5) After the concentrated slurry is pre-filled, the lutein-taurine concentrated slurry is flavored with fructose syrup; and the volume is then adjusted to 50 mL. (7) Shear and disperse evenly again, and filter through a 300-mesh filter; (8) The filtrate was placed in a 50 mL brown glass bottle and sterilized at 100°C for 15 min. (9) Label and store at room temperature.

6. Use of the lutein concentrate formula as claimed in claim 1 in preparing a lutein-containing beverage concentrate.

7. Use of the lutein-taurine concentrate formula according to claim 2 or 3 in preparing a beverage concentrate containing lutein-taurine.